The Summary Notification Information Format for deliberate releases of a GMO or of a combination of GMOs, has been established for the purposes and according to the procedures envisaged by Article 11 of Directive 2001/18/EC.
It is recognized that this Format is not designed to accommodate all the information required for carrying out an environmental risk assessment.
The space provided after each question is not indicative of the depth of the information required for the purposes of the Summary Notification Information Format.
The Summary Notification Information Format consists of a Part 1 and a Part 2.
Part 1 applies to products consisting of or containing genetically modified organisms other than higher plants and contains the following sections:
AGeneral Information
BInformation relating to the recipient or parental organisms from which the GMO is derived
CInformation relating to the genetic modification
DInformation on the organism(s) from which the insert is derived (donor)
EInformation relating to the genetically modified organism
FInformation relating to the release
GInteractions of the GMO with the environment and potential impact on the environment
HInformation relating to monitoring
IInformation on post-release and waste treatment
JInformation on emergency response plans
In Part 1 the information entered should, however, adequately reflect (in a condensed form) the information submitted to the competent authority in accordance with Articles 6 and 7 of Directive 2001/18/EC under the conditions specified in the preface to Annex IIIA.
Part 2 applies to products consisting of or containing genetically modified higher plants. The term ‘higher plants’ means plants which belong to the taxonomic group Gymnospermae and Angiospermae. Part 1 contains the following sections:
AGeneral information
BInformation on the genetically modified plant
CInformation relating to the experimental release
DSummary of the potential environmental impact of the release of the GMPts
EBrief description of any measures taken for the management of risks
FSummary of planned field trials designed to gain new data on the environmental and human health impact of the release.
In Part 2 the information entered should, however, adequately reflect (in a condensed form) the information submitted to the competent authority in accordance with Articles 6 and 7 of Directive 2001/18/EC under the conditions specified in the preface to Annex IIIB.